As the tumor cells express ICAM1, CD58, and CD80 (SI Appendix, Fig. S3C), all of which could contribute to TcE-independent adhesion (46), we used human serum IgGs as a negative control for TcE-specific effects. The gene discussed is CD80; the disease is neoplasm.